Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007–2016

摘要: Abstract Background Human papillomavirus (HPV) vaccination has been routinely recommended at age 11–12 years in the United States for females since 2006 and males 2011. Coverage can be estimated using self/parent-reported HPV collected National Health Nutrition Examination Survey (NHANES) a wider range than other national surveys. We assessed coverage 2015–2016, temporal trends by age, validity of status. Methods Participants aged 9–59 years completed an interview collecting demographic information. Weighted was two-year NHANES cycles group 2007–2008 to 2015–2016 (N = 14318) 2011–2012 (N = 7847). Temporal were from both sexes. Sensitivity specificity provider-verified records pilot study 14–29 year-olds. Results In ≥1 dose among highest 14–19 (54.7%) 20–24 (56.0%) year-olds lower successively older groups. Among males, 14–19 year-olds (39.5%) ages. similar 9–13 year-old males. Between 2011–2012, there increases younger 30 years. female groups including 20–39 year-olds; male increased ages 9–13, 14–19, 20–24 years. Self/parent-reported receipt had sensitivity 87.0% 83.3%. Performance 3 doses. Conclusions While overall remains low, it is higher except 9–13 year-olds. There have many groups, but stalled females. Adequate demonstrated dose, not doses, study.